Filing Details
Advanced Biomed Inc. (NASDAQ:ADVB) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 13, 2026.
The Healthcare company's annual report covers fiscal year 2026.
10k filedNASDAQ:ADVB
Advanced Biomed Inc. (ADVB) Files Annual Report with SEC
Advanced Biomed Inc. (NASDAQ:ADVB) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 13, 2026.
At publication ·
What changed
Advanced Biomed Inc. (NASDAQ:ADVB) · 10k filed
- Form
- 10-K
At a glance
Key takeaways
- Advanced Biomed Inc. filed its 2026 annual report (Form 10-K) with the SEC on October 13, 2026.
- The company's stock trades at $5.16 with a market capitalization of $4.4 million.
- The 10-K filing includes detailed financial statements, management analysis, risk factors, and business segment information beyond what quarterly reports provide.
Market Context
Advanced Biomed Inc.'s stock currently trades at $5.16 with a market capitalization of $4.4M.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For Advanced Biomed Inc. investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for Advanced Biomed Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ADVB Stock Page
Frequently Asked Questions
Where can I read ADVB's SEC filings?
Browse all filings on our ADVB SEC filings page.
What types of SEC filings does Advanced Biomed Inc. file?
Public companies like Advanced Biomed Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.